Zynerba Pharms

ZYNE NASDAQ
10.80
-1.07
-9.01%
After Hours: 10.88 +0.08 +0.74% 19:52 07/19 EDT
Open
11.90
Prev Close
11.87
High
12.04
Low
10.62
Volume
1.85M
Avg Vol (3M)
2.34M
52 Week High
16.47
52 Week Low
2.750
% Turnover
8.78%
Market Cap
227.61M
1D
5D
1M
3M
1Y
5Y

Related

Webull offers Zynerba Pharms ZYNE stock price, real time market quotes, professional analyst ratings, and in-depth charts, You can share investing ideas in community to communicate with others and learn trading skills.

Company Profile

Zynerba Pharmaceuticals, Inc. is a specialty pharmaceutical company. The Company is engaged in developing and commercializing transdermal synthetic cannabinoid treatments for patients with high unmet needs. Its development pipeline includes two product candidates: ZYN002 and ZYN001. ZYN002 is a synthetic cannabidiol (CBD), which is a non-psychoactive cannabinoid, formulated as a patent-protected permeation-enhanced gel for transdermal delivery through the skin and into the circulatory system. ZYN002 is in Phase II clinical development in patients with refractory epilepsy, in patients with osteoarthritis of the knee, as well as in patients with Fragile X syndrome. ZYN001 is a pro-drug of tetrahydrocannabinol (THC) that enables transdermal delivery through the skin and into the circulatory system through a patch. ZYN001 is targeting two pain indications, fibromyalgia and peripheral neuropathic pain.
MORE >

Recently

Name
Price
%Change